BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27830968)

  • 1. Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.
    Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward KC; Howard DH; Lee D; Flowers CR
    Leuk Lymphoma; 2017 Jul; 58(7):1570-1580. PubMed ID: 27830968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of [18F]fluorodeoxyglucose positron emission tomography in the management of follicular lymphoma: the end of a dilemma?
    Janikova A; Bolcak K; Pavlik T; Mayer J; Kral Z
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):287-93. PubMed ID: 18854283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database.
    Abou-Nassar KE; Vanderplas A; Friedberg JW; Abel GA; Niland J; Rodriguez MA; Czuczman MS; Millenson M; Crosby A; Gordon LI; Zelenetz AD; Kaminski M; Lacasce AS
    Leuk Lymphoma; 2013 Oct; 54(10):2155-62. PubMed ID: 23343180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.
    Wong-Sefidan I; Byrtek M; Zhou X; Friedberg JW; Flowers CR; Zelenetz AD; Dawson KL; Reid E
    Leuk Lymphoma; 2017 Apr; 58(4):809-815. PubMed ID: 27562750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
    Lu Z; Lin M; Downe P; Chong S; Ling S
    Ann Nucl Med; 2014 Oct; 28(8):805-11. PubMed ID: 25008291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Informativeness of whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography with computed tomography in follicular lymphoma].
    Nesterova ES; Yatsyk GA; Lutsik NS; Kravchenko SK; Sudarikov AB; Krasil'nikova IV; Gemdzhian EG; Kovrigina AM
    Ter Arkh; 2020 Sep; 92(7):55-62. PubMed ID: 33346445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas.
    Barrington SF; Mikhaeel NG
    Curr Hematol Malig Rep; 2016 Jun; 11(3):185-95. PubMed ID: 27095319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of baseline
    Faudemer J; Aide N; Gac AC; Damaj G; Vilque JP; Lasnon C
    Sci Rep; 2021 Dec; 11(1):23812. PubMed ID: 34893676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma.
    Metser U; Hussey D; Murphy G
    Br J Radiol; 2014 Oct; 87(1042):20140360. PubMed ID: 25061910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.
    Batlevi CL; Sha F; Alperovich A; Ni A; Smith K; Ying Z; Gerecitano JF; Hamlin PA; Horwitz SM; Joffe E; Kumar A; Matasar MJ; Moskowitz AJ; Moskowitz CH; Noy A; Owens C; Palomba LM; Straus D; von Keudell G; Zelenetz AD; Seshan VE; Luminari S; Marcheselli L; Federico M; Younes A
    Eur J Cancer; 2020 Feb; 126():78-90. PubMed ID: 31927165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological prognostic factors in follicular lymphoma patients.
    Jóna Á; Kenyeres A; Barna S; Illés Á; Simon Z
    PLoS One; 2022; 17(8):e0272787. PubMed ID: 35925993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it time for PET-guided therapy in follicular lymphoma?
    Trotman J; Pettitt AR
    Blood; 2022 Mar; 139(11):1631-1641. PubMed ID: 34260714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
    St-Pierre F; Broski SM; LaPlant BR; Maurer MJ; Ristow K; Thanarajasingam G; Macon WR; Habermann TM; Witzig TE
    Oncologist; 2020 Aug; 25(8):689-695. PubMed ID: 32319706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
    Binkley MS; Brady JL; Hajj C; Chelius M; Chau K; Balogh A; Levis M; Filippi AR; Jones M; Ahmed S; MacManus M; Wirth A; Oguchi M; Vistisen AK; Andraos TY; Ng AK; Aleman BMP; Choi SH; Kirova YM; Hardy S; Reinartz G; Eich HT; Bratman SV; Constine LS; Suh CO; Dabaja B; El-Galaly TC; Hodgson DC; Ricardi U; Yahalom J; Mikhaeel NG; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):522-529. PubMed ID: 30858143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.
    Luminari S; Biasoli I; Arcaini L; Versari A; Rusconi C; Merli F; Spina M; Ferreri AJ; Zinzani PL; Gallamini A; Mastronardi S; Boccomini C; Gaidano G; D'Arco AM; Di Raimondo F; Carella AM; Santoro A; Musto P; Federico M
    Ann Oncol; 2013 Aug; 24(8):2108-12. PubMed ID: 23585513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study.
    Kostakoglu L; Goy A; Martinelli G; Caballero D; Crump M; Gaidano G; Baetz T; Buckstein R; Fine G; Fingerle-Rowson G; Berge C; Sahin D; Press O; Sehn L
    Leuk Lymphoma; 2017 Feb; 58(2):372-381. PubMed ID: 27339738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.
    Bishu S; Quigley JM; Bishu SR; Olsasky SM; Stem RA; Shostrom VK; Holdeman KP; Paknikar S; Armitage JO; Hankins JH
    Leuk Lymphoma; 2007 Aug; 48(8):1548-55. PubMed ID: 17701586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma.
    Adams HJA; Kwee TC
    Acta Oncol; 2017 Dec; 56(12):1789-1791. PubMed ID: 28712315
    [No Abstract]   [Full Text] [Related]  

  • 19. Systematic Review on the Additional Value of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging Follicular Lymphoma.
    Adams HJ; Nievelstein RA; Kwee TC
    J Comput Assist Tomogr; 2017 Jan; 41(1):98-103. PubMed ID: 27560022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma.
    Le Dortz L; De Guibert S; Bayat S; Devillers A; Houot R; Rolland Y; Cuggia M; Le Jeune F; Bahri H; Barge ML; Lamy T; Garin E
    Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2307-14. PubMed ID: 20717826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.